AC-46233 - erlotinib-hydrochloride | 183319-69-9
Spiacenti, non è stato trovato nessun prodotto con riferimento AC-46233, ma La invitiamo a verificare i seguenti prodotti simili:
Erlotinib Hydrochloride
CAS:Formula:C22H23N3O4·HClPurezza:>98.0%(T)(HPLC)Colore e forma:White to Light yellow powder to crystalPeso molecolare:429.90Erlotinib Hydrochloride
CAS:Drugs containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structureFormula:C22H23N3O4·HClColore e forma:Pale Yellow PowderPeso molecolare:429.14553Erlotinib hydrochloride
CAS:<p>Erlotinib hydrochloride (NSC 718781) is an EGFR inhibitor (IC50: 2 nM). It is used for the treatment of non-small cell lung cancer.</p>Formula:C22H23N3O4·HClPurezza:99.78% - 99.85%Colore e forma:White Or Off-White PowderPeso molecolare:429.9Erlotinib hydrochloride
CAS:Formula:C22H23N3O4·HClPurezza:≥ 98.0% (dried basis)Colore e forma:White to off-white powderPeso molecolare:429.90Erlotinib hydrochloride
CAS:Formula:C22H24ClN3O4Purezza:98%Colore e forma:Solid, Crystalline PowderPeso molecolare:429.9Erlotinib Hydrochloride
CAS:Prodotto controllatoFormula:C22H23N3O4·ClHColore e forma:NeatPeso molecolare:429.90Erlotinib Hydrochloride Salt
CAS:Erlotinib Hydrochloride SaltFormula:C22H23N3O4·ClHPurezza:By hplc: 99.9% by area (Typical Value in Batch COA)Colore e forma: white to off-white crystalline solidPeso molecolare:429.90g/molErlotinib Hydrochloride (Tarceva)
CAS:Prodotto controllato<p>Applications Selective epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitor. Antineoplastic.<br>References Moyer, J.D., et al.: Cancer Res., 57, 4838 (1997), Hidalgo, M., et al.: J. Clin. Oncol., 19, 3267 (2001), Perez-Soler, R., et al.: J. Clin. Oncol., 22, 3238 (2004), Blackhall, F.H., et al.: Expert Opin. Pharmacother., 6, 995 (2005),<br></p>Formula:C22H23N3O4·ClHColore e forma:White To Light YellowPeso molecolare:429.90Erlotinib hydrochloride - Bio-X ™
CAS:<p>Erlotinib is a drug that is used to treat human malignancies. It is a type of kinase inhibitor that inhibits the EGFR tyrosine kinase, preventing the activation of downstream signalling pathways. Erlotinib has been shown to be effective in treating squamous cell carcinoma, melanoma, and other types of skin cancer. Additionally, Erlotinib has potential for use as an anti-inflammatory agent in the treatment of psoriasis and ulcerative colitis.</p>Formula:C22H23N3O4·HClPurezza:Min. 95%Colore e forma:PowderPeso molecolare:429.9 g/mol
